| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
endogenous retrovirus group K member 6, envelope | 0.521 | 0.808 |
|
disease | 0.100 | None | 1.000 | 41 | 0 | 1992 | 2020 | |||||||||
|
endogenous retrovirus group K member 32, envelope | 0.522 | 0.692 |
|
disease | 0.100 | None | 1.000 | 36 | 0 | 1992 | 2020 | |||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 22 | 0 | 1991 | 2019 | ||||||||
|
influenza virus NS1A binding protein | 0.608 | 0.769 | 0.99 |
|
disease | 0.100 | None | 1.000 | 22 | 0 | 1991 | 2019 | ||||||||
|
SUMO peptidase family member, NEDD8 specific | 0.805 | 0.154 | 5.5E-04 |
|
disease | 0.100 | None | 1.000 | 17 | 0 | 1994 | 2019 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2004 | 2019 | ||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2004 | 2018 | |||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2004 | 2018 | |||||||||
|
limbic system associated membrane protein | 0.558 | 0.654 | 0.99 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2005 | 2018 | ||||||||
|
phospholipase A and acyltransferase 4 | 0.500 | 0.808 | 1.2E-07 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2013 | 2019 | ||||||||
|
lysosomal associated membrane protein 3 | 0.560 | 0.692 | 2.7E-04 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2005 | 2018 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2002 | 2013 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2002 | 2019 | ||||||||
|
interferon induced with helicase C domain 1 | 0.471 | 0.808 | 7.0E-44 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2011 | 2018 | ||||||||
|
endogenous retrovirus group W member 1, envelope | 0.505 | 0.692 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2004 | 2018 | |||||||||
|
endogenous retrovirus group K member 20 | 0.533 | 0.692 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2004 | 2018 | |||||||||
|
roundabout guidance receptor 3 | 0.520 | 0.808 | 2.0E-15 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2014 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2015 | 2019 | ||||||||
|
pigment disorder, reticulate | 0.592 | 0.692 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2013 | 2018 | |||||||||
|
cyclin dependent kinase 9 | 0.498 | 0.769 | 8.9E-05 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2019 | 2020 | ||||||||
|
C-C motif chemokine ligand 5 | 0.403 | 0.885 | 1.8E-03 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2000 | 2019 | ||||||||
|
Raf-1 proto-oncogene, serine/threonine kinase | 0.418 | 0.885 | 0.85 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2013 | 2020 | ||||||||
|
interleukin 4 | 0.332 | 0.962 | 4.7E-03 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2002 | 2020 | ||||||||
|
glutamic--pyruvic transaminase | 0.403 | 0.923 | 3.6E-19 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2015 | 2019 |